ClinConnect ClinConnect Logo
Search / Trial NCT04384718

Assessing the Generalizability of the Tachidino Protocol to Different Clinical Contexts

Launched by IRCCS EUGENIO MEDEA · May 8, 2020

Trial Information

Current as of May 06, 2025

Unknown status

Keywords

Developmental Dyslexia Intervention Hemisphere Specific Stimulation Visual Attentional Training Telerehabilitation

ClinConnect Summary

Specifically, the intervention system based on the web platform "Tachidino" and routinely used for the rehabilitation of reading and spelling disorders at Medea, Lombardy region, would be extended to Marche (precisely, the clinical service connected to Urbino University, located in Pesaro, a coastal town in Central Italy), a different geographical region with different population characteristics. Precisely, the Lombardy region is a highly industrialized region with the highest digitalization rate in Italy, whereas Marche is a more agriculture-oriented region, with lower population density a...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A formal diagnosis of Developmental Dyslexia, Specific Reading Disorders, or Mixed Scholastic Learning Disorders
  • Age between 7 and 16
  • Attending at least the third class of primary school
  • Monolingual speakers of Italian or bilingual speakers with perfect mastery of the Italian language (equivalent to monolinguals)
  • Intelligence Quotient (IQ) \>= 80
  • At least one z-score below -2 Standard Deviations from age mean in at least one of the following tests: text reading, word reading, nonword reading ("DDE-2" battery, "MT" tests)
  • Not having received any specific rehabilitation treatment for dyslexia before
  • Exclusion Criteria:
  • Intellectual disability
  • Neurological disorders
  • Sensory deficits that are not /cannot be corrected-to-normal by lenses or hearing aids.

About Irccs Eugenio Medea

IRCCS Eugenio Medea is a leading clinical research institute based in Italy, dedicated to advancing pediatric healthcare through innovative research and evidence-based practices. As a recognized center of excellence, it focuses on multidisciplinary approaches to address complex health challenges in children and adolescents, particularly in the fields of neurodevelopmental disorders, mental health, and rehabilitation. The institute collaborates with national and international partners to conduct rigorous clinical trials, aiming to translate scientific discoveries into effective therapeutic interventions. Committed to enhancing patient outcomes, IRCCS Eugenio Medea prioritizes ethical standards and patient safety in all its research endeavors.

Locations

Bosisio Parini, Lc, Italy

Pesaro, , Italy

Urbino, , Italy

Patients applied

0 patients applied

Trial Officials

Maria L Lorusso, Ph.D.

Principal Investigator

IRCCS E. Medea

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials